(3,4-dihydroisoquinolin-2(1H)-yl)(4-methoxyphenyl)methanone | 304668-44-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: (3,4-dihydroisoquinolin-2(1H)-yl)(4-methoxyphenyl)methanone
• 英文别名: (3,4-dihydroisoquinolin-2(1H)-yl)4-methoxyphenylmethanone；Methanone, (1,2,3,4-tetrahydro-2-isoquinolyl)(4-methoxyphenyl)-；3,4-dihydro-1H-isoquinolin-2-yl-(4-methoxyphenyl)methanone
• CAS: 304668-44-8
• 化学式: C₁₇H₁₇NO₂
• mdl: MFCD00783894
• 分子量: 267.327
• InChiKey: XXUJYVMHIDEPAF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  苯乙烯 、 (3,4-dihydroisoquinolin-2(1H)-yl)(4-methoxyphenyl)methanone 在 potassium tert-butylate 、 N,N-二甲基甲酰胺 作用下， 反应 0.5h， 以67%的产率得到4-methoxy-N-(3-phenyl-1-(2-vinylphenyl)propyl)benzamide
  参考文献：
  名称：

  Direct Inter- and Intramolecular Addition of Amides to Arylalkenes Promoted by KOt-Bu/DMF

  摘要：

  Direct addition of tetrahydroisoquinoline derived amides to arylalkenes has been achieved in the presence of KOt-Bu/DMF. Both intermolecular and intramolecular reactions could occur in good yields. α-Amido alkyl radicals are proposed to be generated under the reaction conditions. The reaction is efficient for the synthesis of seven-membered nitrogen heterocycles. A homoprotoberberine was prepared conveniently via this method.

  DOI：

  10.1021/jo501179t
• 作为产物：
  描述：

  大茴香酸 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 1.5h， 生成 (3,4-dihydroisoquinolin-2(1H)-yl)(4-methoxyphenyl)methanone
  参考文献：
  名称：

  Direct Inter- and Intramolecular Addition of Amides to Arylalkenes Promoted by KOt-Bu/DMF

  摘要：

  Direct addition of tetrahydroisoquinoline derived amides to arylalkenes has been achieved in the presence of KOt-Bu/DMF. Both intermolecular and intramolecular reactions could occur in good yields. α-Amido alkyl radicals are proposed to be generated under the reaction conditions. The reaction is efficient for the synthesis of seven-membered nitrogen heterocycles. A homoprotoberberine was prepared conveniently via this method.

  DOI：

  10.1021/jo501179t

文献信息

• Palladium-Catalyzed Oxidative Carbonylation of Aryl Hydrazines with CO and O₂ at Atmospheric Pressure
  作者：Yongliang Tu、Lin Yuan、Tao Wang、Changliu Wang、Jiamei Ke、Junfeng Zhao

  DOI：10.1021/acs.joc.7b00499

  日期：2017.5.5

  Palladium-catalyzed aerobic oxidative aminocarbonylation and alkoxycarbonylation reactions with aryl hydrazines as coupling partners have been developed. The oxidative carbonylation of aryl hydrazines proceeded smoothly at atmospheric pressure CO, employing molecular oxygen as the terminal oxidant. The only byproducts were nitrogen gas and water for both reactions. Notably, no double carbonylation

  已经开发了以芳基肼为偶合伙伴的钯催化的需氧氧化氨基羰基化和烷氧基羰基化反应。芳基肼的氧化羰基化反应在大气压CO下顺利进行，采用分子氧作为末端氧化剂。两种反应唯一的副产物是氮气和水。值得注意的是，未检测到双羰基化。此外，通常在常规Pd催化的羰基化反应中具有反应性的芳基-卤素键保持完整。
• Dioxygen-Promoted Pd-Catalyzed Aminocarbonylation of Organoboronic Acids with Amines and CO: A Direct Approach to Tertiary Amides
  作者：Long Ren、Xinwei Li、Ning Jiao

  DOI：10.1021/acs.orglett.6b02913

  日期：2016.11.18

  A direct approach from organoboronic acids and amines to tertiary amides via Pd-catalyzed aerobic aminocarbonylation has been developed. The presence of O2 significantly promotes the efficiency of this transformation. This method uses commercially available organoboronic acids and cheap CO and O2 (1 atm), which renders amides an easy synthesis with broad substrate scope and high functional group tolerance

  已经开发了通过Pd催化的需氧氨基羰基化反应从有机硼酸和胺到叔酰胺的直接方法。O 2的存在显着提高了这种转化的效率。该方法使用可商购的有机硼酸和廉价的CO和O 2（1 atm），这使得酰胺易于合成，具有广泛的底物范围和较高的官能团耐受性。
• 一种绿色环保的合成酰胺键的方法
  申请人：江西师范大学

  公开号：CN106349187A

  公开（公告）日：2017-01-25

  本发明提供一种绿色环保的合成酰胺键的方法，该方法用芳基肼类化合物在氧气的氧化下，与钯催化剂通过氧化脱肼形成C‑Pd键，然后与一氧化碳气体发生插羰基反应形成酰基钯物种，一级或二级胺作为亲核试剂进攻羰基钯后，再通过还原消除得到最后的产物酰胺。本发明实现了钯催化的芳基肼类化合物的胺羰基化反应，以常压CO为羰基源来合成酰胺，其副产物为环境友好的氮气和水。本发明的方法具有新颖、环保、高效的特点，有很大的潜在应用价值。
• COMPOUNDS AND METHODS FOR TREATING PROTEIN FOLDING DISORDERS
  申请人：Carter Michael D.

  公开号：US20100144821A1

  公开（公告）日：2010-06-10

  The invention is directed to compounds and methods for treating protein folder disorders. In certain embodiments the invention provides compounds and methods for treating neurodegenerative diseases such as Alzheimer's disease, tauopathy, cerebral amyloid angiopathy, Lewy body disease, dementia, Huntington's disease and prion-based spongiform encelopathy. The invention further provides compounds, methods and pharmaceutical compositions for inhibiting tau protein, Aβ protein or α-synuclein protein aggregation.

  本发明涉及化合物和方法，用于治疗蛋白质折叠障碍。在某些实施例中，本发明提供了治疗神经退行性疾病，如阿尔茨海默病、tau病、脑淀粉样血管病、Lewy体病、痴呆症、亨廷顿病和基于朊病毒海绵状脑病的化合物和方法。本发明还提供了化合物、方法和制药组合物，用于抑制tau蛋白、Aβ蛋白或α-突触核蛋白的聚集。
• WO2008/58402
  申请人：——

  公开号：——

  公开（公告）日：——